Change history
23 August 2020
The original version of the letter unfortunately contained a mistake.
References
Alconcher LF, Coccia PA, Suarez ADC, Monteverde ML, Perez Y, Gutiérrez MG, Carlopio PM, Missoni ML, Balestracci A, Principi I, Ramírez FB, Estrella P, Micelli S, Leroy DC, Quijada NE, Seminara C, Giordano MI, Hidalgo Solís SB, Saurit M, Caminitti A, Arias A, Rivas M, Risso P, Liern M (2018) Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome. Pediatr Nephrol 33:1791–1798
Balestracci A, Meni Bataglia L, Toledo I, Beaudoin L, Alvarado C (2020) C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome. Pediatr Nephrol 35:331–339
Netti GS, Santangelo L, Paulucci L, Piscopo G, Torres DD, Carbone V, Giordano P, Spadaccino F, Castellano G, Stallone G, Gesualdo L, Chironna M, Ranieri E, Giordano M (2020) Low C3 serum levels predict severe forms of STEC-HUS with neurologic involvement. Front Med 7:357
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics
The study was performed in accordance with the ethical standards of the institutional research and ethics committee.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Balestracci, A., Meni Battaglia, L. C3 levels and neurologic involvement in hemolytic uremic syndrome related to Shiga toxin–producing Escherichia coli. Pediatr Nephrol 35, 2009–2010 (2020). https://doi.org/10.1007/s00467-020-04717-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-020-04717-x